SFM
IMUX icon

Sphera Funds Management’s Immunic IMUX Stock Holding History

Sphera Funds Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-58,321
Closed -$6.59M – 67
2022
Q1 		$6.59M Sell
58,321
-8,339
-13% -$965K 0.93% 32
2021
Q4 		$6.38M Buy
66,660
+27,679
+71% +$2.49M 0.7% 49
2021
Q3 		$3.45M Buy
+38,981
New +$3.84M 0.29% 79
2020
Q3 		– Sell
-10,000
Closed -$1.21M – 105
2020
Q2 		$1.21M Buy
+10,000
New +$1.02M 0.11% 79
2015
Q1 		– Sell
-205
Closed -$2.04M – 157
2014
Q4 		$2.04M Buy
+205
New +$1.58M 0.35% 86

Other funds holding IMUX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Sphera Funds Management's IMUX Position: Q2 2022 in Review

Sphera Funds Management sold out of Immunic (IMUX) in Q2 2022, closing a stake of 58,321 shares — an estimated $6.59M sold.

Sphera Funds Management first reported a position in IMUX in Q4 2014 and held it in 5 quarters. The position peaked at $6.59M in Q1 2022. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Sphera Funds Management reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Sphera Funds Management sold 58,321 Immunic shares in Q2 2022, an estimated $6.59M.
  • Sphera Funds Management first reported a position in Immunic in Q4 2014 and held it in 5 quarters.
  • Sphera Funds Management's Immunic position peaked at $6.59M in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Sphera Funds Management's 13F filing for Q2 2022, filed 15 Aug 2022.